Product NDC: | 21695-900 |
Proprietary Name: | Sildec PE DM |
Non Proprietary Name: | Sildec PE DM |
Active Ingredient(s): | 4; 15; 12.5 mg/5mL; mg/5mL; mg/5mL & nbsp; Sildec PE DM |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 21695-900 |
Labeler Name: | Rebel Distributors Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20100331 |
Package NDC: | 21695-900-16 |
Package Description: | 473 mL in 1 BOTTLE, PLASTIC (21695-900-16) |
NDC Code | 21695-900-16 |
Proprietary Name | Sildec PE DM |
Package Description | 473 mL in 1 BOTTLE, PLASTIC (21695-900-16) |
Product NDC | 21695-900 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sildec PE DM |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 20100331 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | Rebel Distributors Corp |
Substance Name | CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 4; 15; 12.5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes | Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC],Sigma-1 Agonist [EPC],Uncompetitive NMDA Receptor Antagonists [MoA],Sigma-1 Receptor Agonists [MoA],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |